XML 114 R94.htm IDEA: XBRL DOCUMENT v3.6.0.2
Goodwill And Other Intangibles (Schedule Of Changes In Gross Carrying Amount Of Other Intangible Assets) (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2016
Sep. 30, 2016
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Dec. 31, 2016
Definite-lived intangibles:            
Beginning balance           $ 9,170,175
Acquisition of intangible assets           152,591
Impairment of intangible assets           (1,105,191)
Removal of fully amortized intangible assets relating to expired or terminated licensing agreements           (921,816)
Transfer of intangible assets to Assets held for sale (NOTE 3)           (34,600)
Ending balance $ 7,819,650   $ 9,170,175     7,819,650
International Pharmaceuticals            
Definite-lived intangibles:            
Impairment of intangible assets           301,700
U.S. Branded Pharmaceuticals            
Definite-lived intangibles:            
Impairment of intangible assets   $ (72,800)       110,400
Removal of fully amortized intangible assets relating to expired or terminated licensing agreements           (221,900)
U.S. Generic Pharmaceuticals            
Definite-lived intangibles:            
Impairment of intangible assets (507,200)   (38,400) $ (72,400) $ (70,200) 676,800
Other Intangible Assets            
Definite-lived intangibles:            
Beginning balance           9,170,175
Measurement period adjustments relating to acquisitions closed during 2015 (NOTE 5)           (154,500)
Transfer of intangible assets to Assets held for sale (NOTE 3)           (58,281)
Effect of currency translation           8,399
Ending balance $ 7,819,650   $ 9,170,175     7,819,650
Other Intangible Assets | International Pharmaceuticals            
Definite-lived intangibles:            
Sale of certain International Pharmaceuticals intangible assets           (1,959)
Impairment of intangible assets           (301,698)
Other Intangible Assets | U.S. Branded Pharmaceuticals            
Definite-lived intangibles:            
Impairment of intangible assets           (110,430)
Removal of fully amortized intangible assets relating to expired or terminated licensing agreements           (221,853)
Other Intangible Assets | U.S. Generic Pharmaceuticals            
Definite-lived intangibles:            
Impairment of intangible assets           (676,776)
Other Intangible Assets | Voltaren Gel            
Definite-lived intangibles:            
Acquisition of intangible assets           162,700
Other Intangible Assets | Other Acquisition            
Definite-lived intangibles:            
Acquisition of intangible assets           18,183
Other Intangible Assets | XIAFLEX®            
Definite-lived intangibles:            
Capitalization of payments relating to XIAFLEX®           12,008
Other Intangible Assets | Astora            
Definite-lived intangibles:            
Impairment of intangible assets           $ (26,318)